NEW YORK (GenomeWeb News) – Becton Dickinson today reported that its revenues rose 7 percent in its fiscal fourth quarter year over year.

For the three months ended Sept. 30, revenues totaled $2.10 billion, compared to $1.97 billion and beat the average analyst estimate of $2.05 billion.

By segment, BD Diagnostics' revenues increased to $680 million from $645 million, while BD Medical rose to $1.12 billion from $1.05 billion. BD Biosciences was up to $208 million from $185 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.